Rheumatoid Arthritis Recruiting Phase 2 Trials for Bortezomib (DB00188)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02102594Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB)Treatment